What is the Compassionate Access Program?
Anybody who has used medicinal cannabis will know that the cost of prescriptions can quickly mount up. As cannabis products are not licensed in Australia there is no PBS subsidy available. Some health funds are starting to cover part of the cost of the medication, but this remains far from universal. We often come across patients who we feel would benefit from a trial of a medicinal cannabis product, but who simply can’t afford to give it a try.
Medcan Australia have partnered with Cann I Help to establish our Compassionate Access Program. Through the program we are able to subsidize the cost of Medcan products for patients, depending on their clinical and financial situation. We can offer subsidies of up to 50% for patients most at need.
We don’t want any patients to be unable to access medicinal cannabis on cost grounds. The Compassionate Access Program is our way of offering a helping hand.
Mission and Vision
To support the most vulnerable by subsidising cannabinoid medication to those who would benefit from the medication but are unable to access it on financial grounds